SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 102,600
+600 (0.59%)
At close: Jul 25, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.99 trillion as of July 25, 2025. Its market cap has increased by 32.47% in one year.
Market Cap
7.99T
Enterprise Value
7.87T
Revenue
578.00B
Ranking
n/a
PE Ratio
31.80
Stock Price
102,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.99T, a decrease of -19.69%. That is a compound annual growth rate of -4.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.73T |
| Celltrion | 39.71T |
| ALTEOGEN | 25.60T |
| Yuhan | 9,359.37B |
| Peptron | 6,907.66B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 6,057.16B |
| LigaChem Biosciences | 5,227.55B |